BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27450736)

  • 1. Cardioprotection by Thymosin Beta 4.
    Pipes GT; Yang J
    Vitam Horm; 2016; 102():209-26. PubMed ID: 27450736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dimeric thymosin beta 4 with novel bio-activity protects post-ischemic cardiac function by accelerating vascular endothelial cell proliferation.
    Hao Q; He L; Zhou J; Yuan Y; Ma X; Pang Z; Li W; Zhang Y; Zhang W; Zhang C; Li M
    Int J Cardiol; 2018 Jun; 261():146-154. PubMed ID: 29550018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-actin sequestering protein thymosin-β4 regulates the activity of myocardin-related transcription factor.
    Morita T; Hayashi K
    Biochem Biophys Res Commun; 2013 Aug; 437(3):331-5. PubMed ID: 23811404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of thymosin β4 in myocardial infarct and heart failure.
    Stark C; Taimen P; Tarkia M; Pärkkä J; Saraste A; Alastalo TP; Savunen T; Koskenvuo J
    Ann N Y Acad Sci; 2012 Oct; 1269():117-24. PubMed ID: 23045979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin β4 promotes the survival and angiogenesis of transplanted endothelial progenitor cells in the infarcted myocardium.
    Quan Z; Wang QL; Zhou P; Wang GD; Tan YZ; Wang HJ
    Int J Mol Med; 2017 Jun; 39(6):1347-1356. PubMed ID: 28440414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of PTEN/Akt pathway enhances cardiomyogenesis and attenuates adverse left ventricular remodeling following thymosin β4 Overexpressing embryonic stem cell transplantation in the infarcted heart.
    Yan B; Singla RD; Abdelli LS; Singal PK; Singla DK
    PLoS One; 2013; 8(9):e75580. PubMed ID: 24086577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection by systemic dosing of thymosin beta four following ischemic myocardial injury.
    Bao W; Ballard VL; Needle S; Hoang B; Lenhard SC; Tunstead JR; Jucker BM; Willette RN; Pipes GT
    Front Pharmacol; 2013; 4():149. PubMed ID: 24348421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin beta 4 attenuates oxidative stress-induced injury of spinal cord-derived neural stem/progenitor cells through the TLR4/MyD88 pathway.
    Li H; Wang Y; Hu X; Ma B; Zhang H
    Gene; 2019 Jul; 707():136-142. PubMed ID: 31054361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin β4-Enhancing Therapeutic Efficacy of Human Adipose-Derived Stem Cells in Mouse Ischemic Hindlimb Model.
    Kim JH; Lim IR; Park CY; Joo HJ; Noh JM; Choi SC; Hong SJ; Lim DS
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of thymosin β4 from injected collagen-chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction.
    Chiu LL; Reis LA; Momen A; Radisic M
    Regen Med; 2012 Jul; 7(4):523-33. PubMed ID: 22817626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of thymosin beta4 for treatment of patients with ischemic heart disease.
    Crockford D
    Ann N Y Acad Sci; 2007 Sep; 1112():385-95. PubMed ID: 17947592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Progression Is Mediated by Thymosin-β4 through a TGFβ/MRTF Signaling Axis.
    Morita T; Hayashi K
    Mol Cancer Res; 2018 May; 16(5):880-893. PubMed ID: 29330296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymosin β4-mediated protective effects in the heart.
    Hinkel R; Klett K; Bähr A; Kupatt C
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):121-129. PubMed ID: 30063857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the basic and clinical applications of thymosin β4.
    Goldstein AL; Kleinman HK
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S139-45. PubMed ID: 26096726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4.
    Poh KK; Lee PSS; Djohan AH; Galupo MJ; Songco GG; Yeo TC; Tan HC; Richards AM; Ye L
    Cells; 2020 Apr; 9(4):. PubMed ID: 32290541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actin cytoskeletal rearrangement and dysfunction due to activation of the receptor for advanced glycation end products is inhibited by thymosin beta 4.
    Kim S; Kwon J
    J Physiol; 2015 Apr; 593(8):1873-86. PubMed ID: 25640761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymosin β4 released from functionalized self-assembling peptide activates epicardium and enhances repair of infarcted myocardium.
    Wang YL; Yu SN; Shen HR; Wang HJ; Wu XP; Wang QL; Zhou B; Tan YZ
    Theranostics; 2021; 11(9):4262-4280. PubMed ID: 33754060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymosin-β4-mediated therapeutic neovascularization: role of the PI3K/AKT pathway.
    Trenkwalder T; Deindl E; Bongiovanni D; Lee S; Schunkert H; Kupatt C; Hinkel R
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S175-85. PubMed ID: 25652683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actin-Induced Structure in the Beta-Thymosin Family of Intrinsically Disordered Proteins.
    Xue B; Robinson RC
    Vitam Horm; 2016; 102():55-71. PubMed ID: 27450730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction.
    Bollini S; Cheung KK; Riegler J; Dong X; Smart N; Ghionzoli M; Loukogeorgakis SP; Maghsoudlou P; Dubé KN; Riley PR; Lythgoe MF; De Coppi P
    Stem Cells Dev; 2011 Nov; 20(11):1985-94. PubMed ID: 21534857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.